JYOTHYLAB — Jyothy Labs Balance Sheet
0.000.00%
- IN₹124.67bn
- IN₹117.66bn
- IN₹28.47bn
- 89
- 16
- 17
- 33
Annual balance sheet for Jyothy Labs, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 719 | 760 | 2,778 | 6,099 | 7,623 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 1,345 | 1,879 | 1,633 | 2,257 | 2,744 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 6,248 | 7,241 | 7,751 | 11,392 | 14,114 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 3,658 | 3,392 | 3,394 | 3,469 | 3,712 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 19,560 | 20,228 | 20,617 | 24,009 | 26,908 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 4,727 | 5,207 | 4,063 | 4,805 | 5,108 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 5,274 | 5,792 | 5,127 | 5,926 | 6,413 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 14,286 | 14,436 | 15,490 | 18,083 | 20,495 |
Total Liabilities & Shareholders' Equity | 19,560 | 20,228 | 20,617 | 24,009 | 26,908 |
Total Common Shares Outstanding |